Publication Type : Conference Proceedings
Publisher : Elsevier
Source : ESMO Congress 2017. Annals of Oncology, Volume 28, Issue suppl_5, 1 September 2017, mdx374.033, https://doi.org/10.1093/annonc/mdx374.033
Url : https://www.sciencedirect.com/science/article/pii/S0923753420383496?via%3Dihub
Campus : Kochi
School : School of Medicine
Year : 2017
Abstract : Background: Survival benefit of adding chemotherapy to radiotherapy (RT) in patients (pts) age>70 yrs of head and neck squamous cell carcinoma (HNSCC) has not been found in literature. Our institutional policy is to offer concurrent chemoradiation (CCRT) to patients > 70 years with a good ECOG status. Methods: Retrospective analysis of stage III/IV HNSCC in pts > 70 years who received linac based radical CCRT with dose equivalent to 70Gy in conventional fractionation (n = 57) between 2006 to 2014 were included.
Cite this Research Publication : Srinivasalu V K, Subramaniam N, Kumar N, Balasubramaniam D, Philip A, Susan A, Remesan Nair A, Prameela CG, Pushpaja KU, Thankappan K, Jose W, Iyer S, Pavithran K (2017) Do patients over 70 years with advanced head and neck squamous cell carcinoma tolerate curative intent concurrent chemo-radiation? Predictors of oncological outcomes In: ESMO Congress 2017. Annals of Oncology, Volume 28, Issue suppl_5, 1 September 2017, mdx374.033, https://doi.org/10.1093/annonc/mdx374.033